ikdmlogo2.gif (1171 bytes) Indigenous Knowledge and Development Monitor, March 1999


Contents IK Monitor (7-1) | IKDM Homepage | Suggestions to: ikdm@nuffic.nl | (c) copyright Nuffic-CIRAN and contributors 1999.

Ethnobotany, IPR and benefit-sharing: the Forest People's Fund in Suriname
by Edward C. Green, Kenneth J. Goodman, and Martha Hare

The Forest People's Fund provides a concrete example of how local people who share their own knowledge can also share the benefits that accrue from that knowledge. The Fund is a mechanism by which the Maroons and Amerindians of Suriname receive 'up-front' compensation and will share in a pharmaceutical company's future earnings from new drugs found with their help. It could serve as a model for the compensation of intellectual property rights, and help to secure a legal status for indigenous knowledge.

The issues involved in securing a legal status for indigenous knowledge and compensating 'tribal' people for that knowledge are highly complex (Laird 1993; Greaves 1994). There is no consensus among anthropologists and others who work with indigenous people on how this can be achieved. Some argue that any compensation or 'benefit-sharing' flowing from the legal recognition of intellectual property rights (IPR) would actually be a new--legal--form of colonization or 'biopiracy', or that it is detrimental to tribal people in other ways. 1 Others hold that, whatever its limitations, IPR is an important legal instrument by which indigenous people can be protected from exploitation (for overviews, see Greaves 1994; Brush and Stabinsky 1996; FSI & Kothari 1997; IUCN 1997).
In the present context, IPR encompasses what the Convention on Biological Diversity referred to as the 'knowledge, innovations and practices' (UNEP 1992) of indigenous peoples, but which scientists-- and increasingly international development specialists as well--call indigenous knowledge systems. The Inter-Commission Task Force on Indigenous Peoples provided the following definition:

'Indigenous Knowledge Systems are local, community-based systems of knowledge, which are unique to a given culture or society and have developed as that culture has evolved over many generations of inhabiting particular ecosystems. IKS is a general term which refers broadly to the collective knowledge of an Indigenous People about relationships between people, habitat, and nature. It encompasses knowledge commonly known within a community or a people, as well as knowledge which may be known only to a shaman, tribal elders, a lineage group, or a gender group' (IUCN 1997:46).

One prominent arena in which IKS, IPR, and compensation or benefit-sharing arise is in the ethnobotanical search for new drugs in rain forests. The key issues here are: How can the cooperation of indigenous groups in bioprospecting be secured? How should royalties be shared with entire tribal societies? Should compensation be given directly to the indigenous healers whose medical knowledge leads to profitable new drugs? What if no commercially successful new drug can be developed? How can benefit-sharing be made fair and equitable? Who decides what to do with future royalties and other benefits?
These questions are being debated by legal experts, leaders of indigenous groups, anthropologists, and others concerned with conservation and indigenous rights. There are a number of benefit-sharing models which may shed some empirical light on the debate. One of the few models currently in operation was developed in Nigeria, by the Healing Forest Conservancy (HFC), an independent non-profit organization founded by Shaman Pharmaceuticals, Inc. which helped to launch the Fund for Integrated Rural Development and Traditional Medicine (FIRD-TM) in October 1997 (see IK&DM 5(3)). The pilot project was designed to promote the conservation of biodiversity, drug development, and the socioeconomic well-being of local people, and at the same time to test the benefit-sharing process. Following the pilot, the HFC and its partners developed a 'Constitution for Benefit-Sharing through Trust Funds Under the Convention on Biological Diversity' (Moran 1998).
This article focuses on a fund which is similar to FIRD-TM and which has operated in Suriname since 1993. As part of an ICBG project (see box), Conservation International developed the Forest People's Fund (FPF), a mechanism through which 'up-front' compensation and future royalties from new drugs developed by the participating multinational pharmaceutical company can be returned to the Maroons and Amerindians of Suriname. The authors conducted a global evaluation of this ICBG Suriname project (see Betts et al. 1997 for the full evaluation), and the present article focuses on the Forest People's Fund, a concrete case of benefit-sharing and compensation for IPR.


Drying herbal medicines in Suriname prior to chemical analysis in America. Photo: Edward C. Green

International Cooperative Biodiversity Groups (ICBG)

The multi-country ICBG programme was launched in 1992 with funding from the U. S. National Institutes of Health (NIH), the National Science Foundation (NSF), and the U. S. Agency for International Development (USAID). At present, there are six ICBG projects involving ten countries:
- Suriname and Madagascar
- Chile, Mexico, and Argentina
- Mexican Highlands of Chiapas
- Laos and Vietnam
- Nigeria and Cameroon
- Panama

The ICBG employs an experimental, multi-disciplinary, relatively large-scale approach to drug discovery. From the outset it was envisioned that future royalties from lucrative new drugs could promote new, equitable, and ecologically sustainable economic development in source countries. The programme has three inter-related goals: to improve health through the discovery of new drugs from natural sources; to conserve biodiversity, while developing local capacity to manage natural resources; and to promote sustainable economic development (targeted mainly at capacity-building in drug discovery and biodiversity conservation in the source countries themselves).
It was recognized that finding a new chemical compound from rain forest plants and developing it into a new, marketable drug is an uncertain, lengthy and expensive process. This means that future royalties must not be the only economic incentive. Source-country capacity building was seen as a more immediate and sustainable economic development process.
In addition to capacity building, the legal recognition of intellectual property rights pertaining to ethnobotanical and medicinal knowledge is at the heart of ICBG policy in source countries where indigenous people are participating in the drug discovery process.

The ICBG project in Suriname
The Suriname branch of Conservation International (CI/Suriname) took the lead in developing the ICBG proposal for that country. The pharmaceutical partner of ICBG/Suriname was Bristol-Myers Squibb. The Suriname ICBG project allowed for two processes of drug discovery: the ethnobotanical route, in which discovery was assisted by information provided by traditional healers; and the random route, in which no such assistance was involved. CI/Suriname persuaded Bristol-Myers Squibb to provide 'up-front' or 'good-faith' funds (USD 50,000, later increased to USD 60,000) to local forest-dwelling groups, as an incentive to participate in joint drug discovery and develop a workable mechanism for benefit-sharing. After consultations within and between indigenous groups, CI/Suriname helped broker the establishment of the Forest Peoples Fund (FPF). It was agreed that the funds would be used for projects involving community development, biodiversity conservation, and health care.

The Forest People's Fund
A Board of Directors consisting of two members from indigenous communities, two from CI/Suriname, and one from the Department of the Interior was set up to review proposals for the allocation of 'advance payment' and any future royalties from drug sales.
It was agreed between the ICBG partners and the Suriname government that if a drug is derived from ethnobotanical collections, 50% of Suriname's share of any future royalties would go to the FPF and the other 50% to various ICBG partners in Suriname, including CI (10%). If a drug is derived from random collections, the FPF's share would be reduced to 30%, while 70% would go to other ICBG partners.

Evaluation
The ICBG evaluation was carried out between March and December 1997, and included a site visit in June. Information was collected by questioning the ICBG Group Leaders and Associate Program Heads about their program, its goals and its organizational structure. Interviews were conducted with representatives of the ICBG source-country partners, with other relevant organizations and institutions, and with local leaders, traditional healers, and members of the Saramaka village communities. After the site visit, additional information was obtained not only from interviews but also from archival sources and electronic data collection tables.
The site visit team consisted of three persons, all medical anthropologists with experience in evaluation research, ethnobotany, indigenous medical practice, Maroon societies, and sustainable development. One team member (Green) had extensive ethnographic field experience in Suriname and was able to carry out interviews in local languages (Saramakan and Sranan Tongo).
The site visit took five days: three days in the capital city Paramaribo and two days in the Saramaka villages Asindoopo and Akisiamao. One team member stayed behind in Suriname to interview non-Saramakan indigenous and tribal leaders about their awareness and perceptions of the ICBG project.

Findings
Participation
Although the FPF was set up to work with any of the indigenous or tribal peoples of Suriname's interior rain forest, at the time of evaluation only the Saramaka Maroons were participating in the project. Maroons are descendants of escaped African slaves who have lived in the Suriname rain forest for nearly three centuries (see, for example, Green 1977; Price 1976). They are tribally organized and forest-dwelling, but not indigenous to Suriname, although they are related to indigenous Amerindians in various ways.
CI/Suriname gave two reasons for working with the Saramaka people: First, Maroons generally live closer to the capital city Paramaribo than most of the rain forest Amerindian groups. In view of current funding levels and expected constraints on travel costs, it would not feasible to work with Amerindians. Second, CI believed the Saramakas to be the most traditional of the six Maroon societies, so that their traditional ethnomedical knowledge might be more extensive than that of other Maroons.

Allocation of benefits
Saramaka leaders had previously had numerous palavers ('kutus') about how to use the donated funds in ways that would provide on-going income generation and benefit entire communities. Conservation International (both in Washington, D.C. and in Paramaribo) had played a crucial role in steering these discussions. By the time of the evaluation, about half of the available USD 60,000 had been spent on local income-generating projects. The funds had been used to:
- purchase outboard motors and develop a canoe taxi service to transport people and goods upriver to Saramaka territory;
- train local people in catering, for the benefit of ecotourism;
- purchase sewing machines and train women to sew school uniforms, to sell to parents;
- supply tools and training for a commercial gardening project;
- train people in woodcarving, carpentry, and furniture-making.

All of these small-scale projects were thought to have the potential to generate much-needed cash for the Saramakas, in any case those of the upper Suriname river area, where the ICBG is being implemented.


Sketch map of Suriname showing area of current benefit-sharing.

Special arrangement for shamans?
The agreements between the ICBG/Suriname and the FPF did not provide specifically for the sharing of royalties with shamans (traditional healers). As noted above, (see p. 8) this is one of the most important questions related to IPR and benefit-sharing in the context of ethnobotanical drug discovery. For the most part, the ethnobotanical information obtained during the Suriname project was not derived from general or popular plant knowledge, but was made available to the ICBG project by healers. As one lineage chief observed to evaluators, should there not be some kind of special compensation for healers? One factor that had to be taken into consideration was the fact that it challenged Maroon tradition for healers to sell knowledge about medicines to outsiders, or even to share it with them. It was no doubt for this reason that many healers had initially been reluctant to participate in the ICBG, even though their Paramount Chief and local chiefs ('Kapitenis') voted in favour of participation. As ethnobotanical collecting began to develop, traditional healers expressed a preference for being paid about five dollars a day for their participation. Given the advanced age of most of the participants, this may have been not only the best, but also the only, way to compensate them.

Why royalty-sharing?
The healers questioned understood and fully supported local development initiatives. Since it was locally recognized that the ICBG and the Forest People's Fund came to Saramaka territory because of the wisdom of local healers, the presence of the ICBG project and, in particular, the funds made available through the FPF, appear to have boosted the prestige of healers within the community. This observation should be taken as a hypothesis for testing during longer periods of field research in Suriname and in other ICBG country sites.
The leaders gained a better understanding of the biodiversity conservation goals and approved them. Indeed, the Saramaka Paramount Chief (the 'Gaanmam', or 'Gaama'), was willing to sign a contract with Conservation International even before the Suriname government did so. This covered a period of ten years, as opposed to the one-year renewable contract offered by the government.
The Maroons themselves seemed to understand and accept the broader ultimate objectives of the ICBG. Saramakas at all levels were quick to appreciate the immediate, here-and-now benefits of CI's work in their territory, although the rank-and-file Saramakas did not understand the specific purpose of the project. Some saw the ICBG project as a benevolent American project whose goal was 'to bring goods, jobs, and development' ('tja bunu, tja wooko; mbei de konde ko bigi, go a fesi'), rather than something concerned with biodiversity conservation (described in Saramaka as 'mbei di sembe an lasi di matu, solgu di pau matu', meaning: 'not losing the forest, taking care of the virgin forest').

Prospects
It was clear that the community had an interest in local economic development. Given the limited funds available, CI/Suriname was perhaps raising the expectations of Saramakas too high. It focused on bioprospecting, conservation, and making use of funds in ways that would have maximum, sustainable impact. In fact, however, the limitations on funds had kept CI from responding to frequent requests from other tribal leaders to bring the project to other parts of Suriname. There was the case of the Matawai Maroons, whose Paramount Chief was interviewed and confirmed that he would very much like the ICBG to come to Matawai territory. He made such a request to CI and was reportedly told that there were insufficient funds to expand the project into new areas. This chief observed to the evaluator that Maroon and Amerindian villages have become depopulated in the last 25 to 35 years as a result of general economic forces. He felt that the ICBG project could provide an infusion of cash into tribal areas that might slow this process.

Indigenous peoples

Various definitions of indigenous peoples have been proposed, none of them completely satisfactory. The most useful definition would be based on that provided by the World Watch Institute:

They are typically descendants of the original inhabitants of an area taken over by more powerful outsiders. They are distinct from their country's dominant group in language, culture, or religion. Most have a custodial concept of land and other resources, in part defining themselves in relation to the habitat from which they draw their livelihood... And their social relations are often tribal, involving collective management of natural resources, thick networks of bonds between individuals, and group decision making, often by consensus among elders (Durning 1993: 81)
and supplemented by the considerations put forward by the International Working Group for Indigenous Affairs: the criterion of self-identification as indigenous or tribal; the strong, distinctive cultural ties which bind indigenous peoples (language, religion, dress, means of livelihood, etc.); and the fact that they often suffer political deprivation, because they are unable to exercise control over their own affairs (IUCN 1997: 27-30).

Conclusion
The Suriname ICBG project appears to have developed a workable mechanism and model for equitable benefit-sharing, involving a single ethnolinguistic group and a low level of funding. This mechanism was developed by a tribal--but not strictly speaking indigenous--group that is assisting an international conservation organization and a multinational pharmaceutical company in drug discovery.
This process may or may not lead to commercially viable drugs, the sale of which would generate royalties that would benefit Saramaka and other forest peoples. To date, the establishment and operation of the FPF provides evidence of popular participation and sustainable small-scale economic development, as well as cultural and financial appropriateness. One of the advantages of developing and testing a benefit-sharing mechanism, even on a very limited scale, is that it can increase the possibility that larger sums of money will be put to good use, should they become available through drug royalties.
The advance-payment, benefit-sharing experiences of both Suriname and Nigeria should be followed closely, as they may shed light on the complex questions that arise in connection with the sustainable development of bioresources, the recognition of the intellectual property rights of indigenous peoples, and the provision of compensation to indigenous peoples for help in drug discovery.

Edward C. Green
Independent Consultant
2807 38 th st, NW
Washington, DC 20007 USA
E-mail: egreendc@aol.com

Kenneth J. Goodman
Health Researcher Battelle Centers for Public Health Research and Evaluation
2101 Wilson Blvd., Suite 800
Arlington, VA 22201 USA
Tel.: +1-703-875 2101.
Fax: +1-703-527 5640.
E-mail: goodmanj@battelle.org

Martha L. Hare
Battelle Centers for Public Health Research and Evaluation
2101 Wilson Blvd., Suite 800
Arlington, VA 22201 USA
Tel.: +1-703-875 2949.
Fax: +1-703-527 5640.
E-mail: hare@battelle.org

References
- Betts, Claude, Mary Odell Butler, Patricia Godoy-Kain, Kenneth J. Goodman, Edward C. Green, Martha L. Hare, Ann Lesperance, Edward B. Liebow, Richard Weller, and Valerie F. Williams (1997) Evaluation of the International Cooperative Biodiversity Groups Program. Report to the John E. Fogarty International Center, NIH. Arlington, VA: Battelle.
- Brush, S.B. and D. Stabinsky (1996) Valuing local knowledge. Washington, D.C.: Island Press.
- Durning, A.T. (1993) 'Supporting indigenous peoples', in Worldwatch Institute, State of the World 1993. New York: W.W. Norton.
- FSI (Fundación Sabiduría Indígena) and Brij Kothari (1997) 'Rights to the benefits of research: Compensating indigenous peoples for their intellectual contribution', Human Organization Vol. 56, No. 2: 127-137.
- Greaves, Tom (ed.) (1994) Intellectual property rights for indigenous peoples. Oklahoma City: Society for Applied Anthropology.
- Green, E.C. (1977) 'Social control in tribal Afro-America', Anthropological Quarterly Vol. 50(3): 107-116.
- IUCN (Inter-Commission Task Force on Indigenous Peoples) (1997) Indigenous peoples and sustainability: Cases and actions. Utrecht: International Books.
- Laird, S. (1993) 'Contracts for biodiversity prospecting', pp. 99-130 in: World Resources Institute, INBio, Rainforest Alliance and ACTS/Kenya, Biodiversity prospecting: Using genetic resources for sustainable development. Washington, D.C: World Resources Institute.
- Moran, Katy (1998) Mechanisms for benefit-sharing: Nigerian case study for the Convention on Biological Diversity. Washington, D.C.: the Healing Forest Conservancy.
- Posey, D. and G. Dutfield (1996) Beyond intellectual property: Toward traditional resource rights for indigenous peoples and local communities. Ottawa: IDRC.
- Price, R. (1976) The Guiana Maroons. Baltimore: The Johns Hopkins University Press.
- United Nations Environment Program (UNEP) (1992) Convention on Biological Diversity. Rio de Janeiro, Brazil, June 5.

Endnote
1 Some scientists prefer the term traditional resource rights (TRR) to IPR since it is more inclusive, embracing 'bundles of rights' beyond those pertaining to knowledge such as religious freedom, land rights, rights to privacy, etc. (IUCN 1997:99-100; Posey & Dutfield 1996). However, we wish to restrict discussion here to rights related to knowledge.


Back to: top of the page | Contents IK Monitor (7-1) | IKDM Homepage
Suggestions to: ikdm@nuffic.nl
(c) copyright Nuffic-CIRAN and contributors 1999.